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ABSTRACT 
Red meat consumption has been associated with negative health effects. A study to identify 
biomarkers of meat consumption was undertaken using serum samples collected from 
combining high resolution mass spectrometry (UPLC-QTof-MS) and chemometrics. Using 
orthogonal partial last-squares discriminant analysis (OPLS-DA), multivariate models were 
created for both modes of acquisition (ESI-/ESI+) and red meat intake classes (YES/NO). In 
the serum samples, a total 3280 and 3225 ions of interest were detected in positive and 
negative modes, respectively. Of these, 62 were found to be significantly different (p<0.05) 
between the two groups. Glycerophospholipids as well as other family lipids, such as 
lysophospholipids or sphingomyelin, were found significantly (p<0.05) different between yes 
and no red meat intake groups. This study has shown metabolomics fingerprints have the 
capability to identify potential biomarkers of red meat consumption, as well as possible 
health risk factors (e.g., key metabolic families related to the risk of development type 2 
diabetes).  
 
Keywords: Red meat consumption, biomarkers analysis, UPLC-QTof-MS, metabolomics, 
lipids, health risk factors, Diabetes 
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1. Introduction 
Meat consumption is an important contributor to dietary protein in omnivorous populations, 
and therefore has a potential impact on a range of nutritional and health outcomes. In many 
western countries, and increasingly worldwide, a typical lifestyle is characterized by a diet 
high in fat, calories and red meat, and low in fruits, vegetables and fiber. An increasing 
number of epidemiological studies have associated red and processed meat consumption with 
the development of the major chronic diseases of the Western world; diabetes, coronary 
disease and colon cancer (IARC 2015, Cross et al., 2007; Giovannucci et al., 1994; Kelemen, 
Kushi, Jacobs, & Cerhan, 2005; Kontogianni et al., 2008, Song et al., 2004). Constituents of 
red meat that have been proposed to be responsible for these associations, include the fat 
content, fatty acid composition and the possible formation of carcinogenic compounds, such 
as heterocyclic amines (HCAs), by cooking meat at high temperatures (Bingham et al., 2002). 
Although there are many studies documenting these associations, the results generated have 
not always been consistent and there are several methodological issues which limit the 
strength of their findings. In the same way as risks to human health from excessive red meat 
consumption may result, there are many health benefits of consuming red meat based on its 
nutritional composition. Red meat intake has most often been assessed using food frequency 
questionnaires, diet records or measurements of others parameters, although this is unspecific 
(Roberts et al., 1991, Leiba et al., 2005). These assessment methods have also been used 
extensively for studies on different kinds of meat (red vs. white), and on the influence of 
cooking methods. Several attempts have been made to find reliable markers of meat intake. 
Such markers would ideally reflect specific compounds in meat that distinguishes its intake 
from other foods and food groups. The development of robust food biomarkers will help in 
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better classifying an individual’s dietary intake and, in turn, will improve the assessment of 
the relationship between diet, health and chronic disease (Heinzmann et al., 2010). In recent 
years there has been an increased interest in applying metabolomics for the discovery of 
biomarkers of dietary intake. Recent proteomic studies have shown that short chain fatty 
acids (such as butyrate) generated from microbial digestion of dietary fiber may have 
important protective functions against gut cancers (Tan et al., 2006). Any alteration of the 
physiological status can disrupt homeostasis, resulting in perturbations of the levels of 
endogenous biochemicals that are involved in key metabolic processes in the cells and tissues 
of an organism (Nicholson & Wilson, 2003). To maintain homeostasis, and to adjust for the 
changes in tissue biochemistry, the composition of the body will be altered accordingly and 
lead to different and dynamic “metabotypes” that may not be observable from gross 
examination of the phenotype. Thus, monitoring perturbations in biofluid composition 
specifically due to diet preferences may yield valuable information regarding underlying 
molecular mechanisms. The quantitative measurement of the dynamic multiparametric 
metabolic response of living systems to pathophysiological stimuli or genetic modification is 
termed metabonomics (Nicholson et al., 1999) and largely relies on chemometric analysis of 
high resolution spectral data (e.g., NMR or Q-Tof-MS). 
The combination of high resolution liquid chromatography-quadrupole time-of-flight-mass 
spectrometry (UPLC-QTof-MS) and chemometrics has not been previously applied for 
biochemically profiling serum samples in relation to red meat intake levels. The aim of this 
investigation was to assess the relative analytical power and potential usefulness of UPLC-
QTof-MS for studying the polar metabolite fingerprint present due to different levels of red 
meat intake and to identify potential biomarkers (metabolites) of consumption. 
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2. Materials and methods 
2.1. Serum samples 
Serum samples were obtained from the research project FoodCAP funded by the 
World Cancer Research Fund (Grant ID 2010/255). As part of this project, a randomized 
dietary intervention study was conducted.  Initially, participants were screened for habitual 
meat intake, via completion of a 7 day food diary.  Participants were recruited via poster and 
email advertisement and through word-of-mouth, they were given full study information and 
screened for eligibility. Those under 18 years were excluded as were smokers, due to 
potential exposure to polycyclic aromatic hydrocarbons. Eligible participants provided 
written informed consent. They received a 7-day food diary and detailed instructions on how 
to record their dietary intake. Participants were asked to record their dietary intake for seven 
consecutive days and to return within two days of completing their diary.  Those in the top 
33% of habitual meat intake were re-contacted and re-consented to take part in six week 
dietary intervention study. They were randomly allocated (using www.randomisation.com) to 
(i) remove all meat from their diet (high red meat intake (HRMI) group), or (ii) continue with 
their usual diet (control group), for 6 weeks. Each participant in the HRMI group was advised 
how to lower their meat for the intervention period. Participants were given personalized 
advice to achieve this and were instructed to employ food substitutions, with due recognition 
to the individuals’ usual dietary habits and personal food likes and dislikes. Where 
appropriate, participants were provided with a choice of meat free meals (commercially 
available branded products) to assist them in complying with the intervention. Participants 
were asked to complete a second food diary mid-way through intervention as a record of 
actual food consumption during intervention. Where issues of compliance arose, they were 
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addressed at this mid-way point. The control group continued to consume their usual diet. 
They provided blood samples and completed questionnaires as for HRMI group participants. 
2.2. Blood collection 
Participants were instructed to fast (water only allowed) for at least 12 h prior to 
attending each study visit at baseline (t0), after three weeks (t1) and after six weeks (t2). 
Participants provided a 50 ml blood sample, collected in anticoagulant plasma tubes and 
serum tubes, by staff trained in venepuncture. Serum tubes were allowed to coagulate at room 
temperature for approximately 1 h, while plasma tubes were refrigerated. Serum and plasma 
were obtained by centrifugation, and were aliquoted and stored at -80°C.  Each completed 
food diary was reviewed at the time of collection with a researcher to ensure correct 
completion. Analysis of food diaries (examining food intake and also through analysis of 
nutrient intake using the dietary analysis program WISP v3.0 (Tinuviel, UK), confirmed 
compliance with the dietary intervention.  A total of 31 participants completed the 
intervention. 
This study was conducted according to the guidelines laid down in the declaration of 
Helsinki and all procedures involving human subjects were approved by the School of 
Medicine, Dentistry and Biomedical Sciences Research Ethics Committee of Queen’s 
University, Belfast.  
2.3. Sample extraction 
Extracted serum samples for metabolomics analysis (polar metabolites) were obtained 
using a minimal sample preparation method. Briefly, for each intervention sample a 100 µl 
aliquot of serum was transferred into a 2 ml sterile Eppendorf tube then 400 µl of ice cold 
methanol were added. The samples were mixed (5 sec) in a vortex, and then centrifuged for 
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15 min at 16,000 g at 4oC. The supernatant layer was transferred to another 2 ml Eppendorf 
tube and vacuum dried overnight. Dry extract were then reconstituted into 100 µl of milli-Q 
water, transferred in to a 2 ml Spin-X Centrifuge tube filter (Corning Incorporated, Corning, 
NY 14831, USA) and centrifuged for 15 min at 16,000 g at 4oC. Filtered extract were then 
transferred to a 2 ml Square Collection Plate (Water, Milford, MA, USA) for UPLC-QTof-
MS analysis.  
2.4. UPLC-QTof-MS analysis 
30 samples were analyzed (in triplicate, n= 90), from t0, t1 and t2 (high red meat intake 
n=48, no red meat intake n= 45). A UPLC I-Class system (Waters Acquity, Milford, MA, 
USA) was used for chromatographic purposes, coupled to a mass spectrometer (Waters Xevo 
G2S QTof mass spectrometer (Manchester, UK) equipped with an ESI (electrospray 
ionization source) with lock-spray interface for accurate mass correction in real time. The 
source temperature and cone gas flow were set at 120°C and 50 l/h, respectively. Meanwhile, 
desolvation temperature and gas flow were set up at 450°C, and 850 l/h, respectively. The 
capillary voltage was set at 1.0 kV and 1.5 kV in ESI+ and ESI-, respectively with a cone 
voltage of 30 V operating in both mode. Leucine Enkephalin (2 ng.µl-1) in methanol/water 
with 0.1% formic acid (1:1, v/v) was used as a lock mass solution, which was infused into the 
MS with a flow rate of 5 µl.min-1. Mass spectra data were acquired in continuum mode using 
MSE function (in low energy: 4eV and high energy: ramp from 20-35 eV) over the range m/z 
50–1200 range with a scan time of 0.08s. A 5.0 µl of the sample was injected onto an Acquity 
UPLC HSS T3 column (2.1 x 100 mm, 1.8 µm, Waters, Milford,USA) mounted with a guard 
column (HSS T3 VanGuard Pre-column, 2.1 mm x 5 mm, 1.8 µm, Waters, Milford, MA, 
USA). The column oven and the sample manager temperatures were 45°Cand 10°C, 
respectively. The elution buffers were A (water with 0.1% formic acid) and B (methanol with 
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0.1% formic acid), with a flow rate of 0.4 ml.min-1. The elution gradient (A:B, v/v) was: 2 
min at 99:1 isocratic, followed by a linear gradient from 99:1 to 15:85 over 4 min then a 
linear change from 15:85 to 10:90 over 3 min and finally a linear gradient from 10:90 to 1:99 
over 7 min. After a 2 min period at 1:99, initial composition 99:1 was restored and held for 2 
min before the next injection. Samples were injected in triplicate in negative (ESI-) and 
positive (ESI+) ionization. For chromatographic performance (i.e., reproducibility of 
retention times and peak intensities) 10 pooled samples were injected prior to the analysis and 
every 10 target samples another small set of pooled samples (5) were injected from beginning 
to end of the run (Oresic et al., 2011). 
2.5. Data analysis 
The generated spectra data was handled using Progenesis QI v2.0 Software (Waters, 
Newcastle, UK), this is a specific software package for metabolomics analysis that permit to 
accurately treat high resolution LC-MS spectral data. This software assisted in the validation 
of LC-MS approaches and identification of features within the spectral data. Using 
Progenesis QI the spectral data were aligned to a chosen pooled sample, adduct ions were 
deconvoluted and ion abundance above the threshold level performed. All ions detected were 
selected against the Lipid Blast database, Chemspider and Progenesis Metascope spectral 
libraries which provide identifications for 15-30% of the assigned ions. The analyzed data 
was exported to Simca 14 (Umetrics, Umea, Sweden) for multivariate analysis. Data quality 
was evaluated in terms of reproducibility using an approach utilize in others works by Spagou 
et al., 2011. As a quality control estimate all the spectral data were mean centered, pareto 
scaled and analyzed with principal components analysis (PCA). For both ESI+ and ESI− 
acquisition modes, the data were divided into high red meat intake and no red meat intake 
prior to analysis using orthogonal projection to latent structures-discriminant analysis (OPLS-
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DA). Red meat intake was analyzed for two different levels of consumption (yes and no) at 
different times during the intervention study, the initial baseline samples (to) and the post 
intervention samples at 6 weeks (t2). Statistical analysis approach was performed following 
the proposed minimum reporting standards for data analysis in metabolomics by Goodacre et 
al., 2007.  More details about statistical models used can be found in the Supporting 
Information material and in an earlier work by Graham et al., 2013. In each of the models 
(n=2), all of the test set observations were correctly assigned to exposure levels (yes and no) 
groups 100% of the time for both ESI+ and ESI− (available in Figures S1 and S2, Supporting 
Information). Target ions which were different between groups (high and no red meat intake) 
were analyzed using a two tailed student t-test. The top 100 compounds responsible for the 
fluctuation in the discriminant model were picked from the variable importance plot (VIP) in 
the two cases, and subjected to univariate analysis (the same procedure were applied for the 
initial intervention samples , t0 in order to compare similar ions (i.e., compounds of interest) 
in both groups).  
 
3. Results and discussion 
3.1. Characteristics of the population studied 
The average age of participants was 30.5 years in both men (n=16) and women 
(n=14). About 6% were obese (BMI≥30 kg/m2). The group for red meat intake comprised of 
14 individuals and the control group had 16 individuals. No significant differences (p>0.05) 
were found between groups for BMI (18.16 kg/m2 and 18.07 kg/m2 and age 30.2 years and 
31.1 years, respectively).  
3.2. Red meat intake models of exposure  
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3.2.1. Models of Exposure at the end of the study (t2) 
Figure 1A shows a chromatogram acquired in ESI- for a target serum sample and the 
corresponding pool serum sample (pink and green line, respectively). Orthogonal partial 
least-squares discriminant analysis (OPLS-DA) was used to develop a model enabled to 
differentiate between no red meat intake (blue) and high red meat intake (red), in serum 
samples (n=75). Figure 1B shows the score plot with the results of the model building, with 
one component and eight orthogonal projections which demonstrate the highest load of 
variation between the two groups (R2 (cum) = 97%; Q2 = 86%; root mean squared error for 
validation (RMSEV) = 18%. Figure 1C displays the loading plots correlated to the scores plot 
in Figure 1B (reveals the compounds that are the reason for the variation between the two 
samples groups). Featured in blue (no red meat intake, n = 15) and red (high red meat intake, 
n = 15) were the ions which shows significant differences between sample groups. The S-plot 
in Figure 1D reveals the proportional importance of each molecule in discriminate sample 
groups. Peak height and colour point out relative significance of the candidate molecules. 
Table 1 shows the retention times, exact masses, percentage increment and their significance 
values (p<0.05). Figures 2A and 2B show the proportional abundance of all the ions (ESI-) of 
concern within the two sample groups (yes vs no red meat intake, respectively), including the 
standard error of the mean (error bars). 
In Figure 3A a chromatogram acquired in positive mode of the sample and the corresponding 
pool serum sample (pink and green line, respectively) is shown. The same scheme was 
applied for data analysis as in the former described negative mode acquisition, and 3225 ions 
were detected by Progenesis QI. The OLPS-DA scores model shown in Figure 3B (n=83), 
was built with one component and eight orthogonal projections to elucidate the maximum 
amount of variation within the two sample groups (R2 (cum) = 94%; Q2 (cum) = 89%; 
RMSEV= 17%). Figure 3C shows the loading plots in accordance to the compounds that are 
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accountable for the variation between the two samples groups. Displayed in blue (high red 
meat intake, n = 15) were the ions which showed significant differences between groups, no 
significant differences in compounds were observed for no red meat intake. Figure 3D shows 
the significance and relative importance of the ions found in Fig.3C. Table 2 remarks the 
retention times, masses, percentage of increase between sample groups, and their significance 
values (only ions with p<0.05 are shown) of the ions. Figure 4A shows the relative 
abundance of all the ions (ESI+) of interest between the two sample groups (high red meat 
intake), including the standard error of the mean (error bars). Models of exposure at the 
beginning of the study (t0) can be found in the SI material. 
3.3. Biomarker identification 
Progenesis QI provided 3075 possible identifications for the 3400 ions found to be present in 
the target samples extracts (t2 post intervention samples). Nevertheless only a small number 
of these features were presumed identified using Progenesis QI, with only 32 (ESI+) and 30 
(ESI-) being in the top 100 metabolites emphasize by the VIP (Variable Importance Plot). 
The tentatively identified compounds which may be candidates for probable metabolite 
biomarkers of red meat intake, need to be interpreted with a degree of caution as the 
identification is not 100% accurate. We followed the recommendations for standard 
metabolite identification established by the Chemical Analysis Working Group (CAWG) of 
the Metabolomics Standard Initiative by Sumner et al. 2007. Therefore we describe our 
identified compounds as putatively annotated compounds (type 2) or putatively characterized 
compound class (type 3). In addition, for a specific m/z more than one possible compound 
can be listed as a possible candidate. Further research is required to compare the fractionation 
patterns and retention times of the potential identified compounds against reference standards 
using UPLC-MS/MS. Within the tentatively identified compounds, we were able to reveal 
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important lipids families (e.g. Glycerophospholipids), and within this class: 
Glycerophosphocholines (GP01) and Glycerophosphoethanolamines (GP02), and sub-
classes: Monoacylglycero-phosphocholines (GP0105) and 1Z-
alkenylglycerophosphoethanolamines (GP0207), as well other important lipid families, such 
as Lysophospholipids, Phosphatidylcholine or Sphingomyelin, were identified and found 
significantly different between groups, some were upregulated  and others down regulated 
(p<0.05) (Figures 2A, 2B, 4, S5, S6 and S7). Glycerophosphocholines have previously been 
associated with a “meat factor” which is reported to enhance non-heme iron absorption 
(Armah et al., 2008), this compound could be used as a positive biomarker of red meat intake. 
For the VIP plot, 32 compounds were significantly different (p<0.05) in the ESI+, for the 
high red meat intake group, surprisingly no compounds were significantly different in the ‘no 
red meat' intake group. For the VIP plot, 15 compounds were significantly different (p<0.05) 
in the ESI-, between the high red meat intake group vs the no red meat intake group and 15 
compounds between the no red meat intake and the high red meat intake group. For the 62 
compounds, which were significantly different from high vs no exposure, 18 were positively 
“identified”. Table S1 shows the presumptive identifications of these 18 compounds. 
Three compounds (m/z 464.3140- PE(P-18:0/0:0); m/z 724.5279- PE(P-16:0/20:3) and m/z 
726.5447- PE(18:1(9Z)/18:1(9Z)) which are related to the Glycerophosphoethanolamines 
(GP02) specific to the 1Z-alkenylglycerophosphoethanolamines (GP0207) (ID level type 2 or 
type 3, Table S1), were found for ESI- mode in high red meat intake, these compounds have 
two different origins (endogenous and food) and have been linked  to have a cell signaling, 
energy source/storage function, as well as being components of cell membranes 
(www.hmbd.ca). Other compounds identified as being significantly higher in the red meat 
intake group were Sphingomyelin d18:C18:0, (m/z 775.5959) and Phosphatidylserine 18:0-
18:1, (m/z 786.5647) (ID level type 3, Table S1). Sphingomyelin altered levels have been 
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shown to be markers of a number of different metabolic syndromes (e.g., obesity, insulin 
resistance of fatty liver disease) (Hanamatsu et al., 2014).  Phosphatidylserines have different 
biological functions in the human body, such as cell signaling membrane component and 
energy storage (www.hmbd.ca). 
Seven compounds (m/z 517.3173- PC(18:3/0:0); m/z 519.3321- PC(18:2/0:0); m/z 545.3487- 
PC(20:3/0:0); m/z 729.5316-GPCho(6:0/26:2); m/z 743.5481- GPCho(16:0/17:2); m/z 
782.5708- GPCho(14:0/22:4) and m/z 799.6692), all belonging to the Glycerophospholipids 
class (GP01) and Monoacylglycero-phosphocholines sub-class (GP0105) were found in ESI+ 
mode in the high red meat intake group (ID level type 2 or type 3, Table S1). This family of 
compounds has been previously reported as potential biomarkers of red meat consumption 
and was related to a higher risk of type 2 diabetes (Wittenbecher et al., 2015). Within the 
presumptive 18 identified compounds in Table S1 (ID level type 2 or type 3), 16 were up-
regulated in the HRMI group compared to the control. 
This is the first study that combines high resolution UPLS-QTof-MS and chemometrics to 
biochemically profile the polar metabolome in human serum samples in an effort to evaluate 
diet preferences (red meat intake yes or not). By acquiring MS data in negative and positive 
modes, two separate metabolomics models were developed which can clearly and 
unambiguously distinguished high vs low levels of contaminant exposure. The predictive 
accuracy of the models were excellent with a range of Q2= 77 - 93% and RMSEV, 12 - 18%. 
The predictability of the model could be increased if a larger number of samples are 
measured. Data acquired in positive mode assigned a total of 3076 polar compounds while 
data acquired in negative mode assigned 3121 polar compounds. It has been possible to 
assess the variable importance of a number of ions which were highlighted by their respective 
colours in the S-line-plot. The S-plot allowed the visual determination of the ions of interest 
most responsible for separating the two study groups (high vs no red meat intake). It was then 
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possible to statistically analyze each of the ions of interest and verify (by means of a t-test) 
that these candidates were significantly different in each level of exposure (Table 1 and 2).  
In order to search for possible metabolite correlations between the initial (t0) and the final 
intervention samples after the six weeks study (t2), the VIP plot ions (100) for ESI-/ESI+ and 
red meat intake groups were investigated. For the 400 ions analyzed only 38 ions were 
significantly different within both study groups (figure S5, S6 and S7, SI material). An 
additional comparison of these ions within t2 and t0 samples, shows that only 8 of these ions 
were also significantly different between the two groups analyzed for the last samples of the 
intervention study (t2). The tentative identification of these compounds can be found in Table 
S2. A number of other observational studies have used metabolomic (NMR spectroscopy) 
analysis of serum or urine samples to examine associations with  red meat intake (Stella et al., 
2006; Bertram et al., 2007a, 2007b), showing some similarities in results for biomarkers 
identified (e.g., Glycerophospholipids), these support the findings of the present study. 
Within the assigned compounds in both modes, 62 compounds showed significant differences 
(p<0.05), in the ESI+ mode, 32 compounds were found for the high red meat intake group, 
but surprisingly none were significantly different (between groups) in the no red meat intake 
group (Table 1 and 2, only show the top 15 of each group (high red meat and no red meat 
intake) and for both acquisition modes, 45 ions in total). For the ESI- mode 15 compounds 
were significantly different (p<0.05) for the high red meat intake group and 15 compounds 
for the no red meat intake, encompassed important lipid families (e.g. 
Glycerophosphoethanolamines (GP02) or Glycerophospholipids (GP01)). This demonstrates 
the strength of this method for tracking biochemical changes in serum samples in response to 
dietary change. We were able to positively identify (as putative annotated compounds type 2 
or putative characterized compound classes type 3) important lipids classes, such as 
Glycerophosphocholines (GP01) and Glycerophosphoethanolamines (GP02), 
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Lysophospholipids, Phosphatidylcholine, Sphingomyelin or Monoacylglycero-
phosphocholines, which are involved in lipid metabolism (cell signaling, fuel storage/source 
or membrane function/component).  
4. Conclusions 
In the present study an effect of changing red meat intake on the levels of a range of different 
lipids families was found and these, or at least a number of them, have the potential to be 
used as positive biomarkers of red meat consumption (i.e., Glycerophosphocholines (GP01). 
The data generated shows that red meat consumption contributed to a rather different 
metabolic fingerprint among the study population. A deregulated lipidomic profile, through 
the enrichment (up-regulated) of lipid metabolites that contain 16 or more carbons atoms in 
the fatty acid residues in which one fatty acid was contained (lysophospoatidylcholines and 
sphingomyelin) or 34 or more carbon atoms in which 2 fatty acids were contained (diacyl 
phosphatidylcholines and acyl-alkyl phosphatidylcholines) is plausibly related to the high 
proportion of even-numbered long-chained fatty acids contained in red meats (Williams, 
2007). Several studies have related altered lipid metabolism to the pathogenesis of type 2 
diabetes, among them a challenged mitochondrial metabolism, altered cellular signaling 
processes at the membrane, and modulation of gene expression (Ye, 2013; Amati, 2012). 
Thus, using the data in Table S2, we proposed a ratio of compounds as a possible biomarker 
index of red meat intake. We used the sum of three compounds (a lysophosphatidylcholine, 
LysoPC(18:2(9Z,12Z)), a sphingomyelin SM(d18:1/16:0) and a diacyl phosphatidylcholine 
PC(20:4(5Z,8Z,11Z,14Z)/16:0) at the beginning of the study (t0) and at the end of the study 
(t2). The ratios for the “biomarker index” was 0.97 for the t0 samples and 1.23 for the t2 
samples, this result is in agreement (an increasing ratio towards the end of the study) with 
what was expected, i.e. a higher metabolomic difference between both groups over the 
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experiment time. Thus, serum levels of multiple lipids can subtly reflect the status of a 
metabolic system in response to a change in food group intake, in this case red meat 
consumption (e.g., through the id compounds and the “biomarker ratio”) as well as possible 
health risk factors (e.g., key metabolic families related to the risk of development diabetes 2 
type).  
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Table 1. Molecules of interest as identified in the S-Line Plot (ESI-), for the significance to 
the Model+  
    
        negative mode acquisition      
 higher in high red meat intake             higher in no red meat intake 
 
   
 
no 
 
Rt mass % increase p-value n0 Rt mass % increase p-value 
1 5.33 255.0877 270.1 5.8 x 10-04 1 4.16 171.0116 625.34 2.6 x 10-09 
2 5.17 1012.4874 349.9 8.5 x 10-04 2 5.60 385.1690 208.3 0.005 
3 6.41 367.1585 154.5 7.4 x 10-03 3 5.71 462.1766 307.5 1.9 x 10-05 
4 6.86 369.1734 160.1 0.01 4 6.75 624.3390 180.4 0.009 
5 6.87 397.2054 141.1 0.01 5 6.97 481.3521 188.3 0.00021 
6 7.10 448.3060 51.5 0.004 6 7.02 567.3163 429.3 1.2 x 10-06 
7 8.61 479.3344 121.9 0.001 7 7.32 471.2425 24.2 0.02 
8 8.63 437.2899 133.3 0.004 8 7.33 621.3271 1605.2 0.0005 
9 9.22 327.2325 137.7 0.03 9 7.50 392.2923 302.5 0.007 
10   9.71  464.3140      137.7 0.001 10 7.57 391.2847 351.7 0.007 
11 14.95 485.2724       121.6 0.01 11 7.60 481.3521 154.6 0.0008 
12 15.69 775.5959       122.1 0.003 12 9.35 595.2888 70.8 0.006 
13 15.91 786.5647       124.3 0.004 13 14.20 824.5444 67.8 0.01 
14 16.08 724.5279       132.2 0.03 14 15.36 738.5071 78.1 0.02 
15 17.01 726.5447       146.3 0.0008 15 15.62 764.5234 63.4 0.005 
+Accompanying are the respective results from the Student’s t-test carried out for the high red meat intake level compared to 
low red meat intake. The results correspond to the S-line plot in Figure 1 which are numbered accordingly. 
 
Table 2. Molecules of interest as identified in the S-Line Plot (ESI+), for the significance to 
the Model+ 
 
+Accompanying are the respective results from the Student’s t-test carried out for the high red meat intake levels compared 
to low red meat intake. The results correspond to the S-line plot in Figure 3 which are numbered accordingly.  
 
    
         positive mode acquisition      
                                                                higher in high red meat intake 
n0 Rt mass % increase p-value n0 Rt mass % increase p-value 
1 7.55 517.3173 165.9 0.0005 9 13.30 674.5371    134.2 0.0003 
2 7.73 240.6845 149.9 0.0008 10 13.66 700.5527    129.9 0.0003 
3 7.74 1039.6697 212.7 0.0002 11 13.94 689.5601    128.1 0.001 
4 7.91 519.3321 144.8 0.001 12 14.23 729.5316    141.9 0.002 
5 7.97 1015.6722 144.2 0.009 13 14.83 743.54810    130.8 0.0006 
6   8.25 545.3487    141.3 0.004 14 14.97 782.5708    139.2 0.001 
7 12.00 646.5051    148.9 0.001 15 17.79 799.6692    123.7 0.001 
8 12.36 673.5283    151.8 0.00003      
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Figure captions 
Figure 1. (A) UPLC ESI- chromatogram of the polar extract of a serum sample. (B) The 
scores plot displaying the separation between the two sample groups (no red meat intake = 
blue; high red meat intake = red). Explained variance (R2) was 97%, predictive ability (Q2) 
was 86%, and root-mean-square error of validation (RMSEV) was 18%. (C) The loadings 
plots which correspond to the scores in B. Indicated in blue (n = 15) and red (n = 15) are 
metabolites which significantly differ between groups (higher in no red meat intake and high 
in high red meat intake, respectively). These are further emphasized by the S-line-plot (D) 
and their relative variable importance to the model. 
Figure 2. Graphical representation of the mean relative abundances of the molecules found to 
be significantly different between sample groups acquired in negative mode for high red meat 
intake and no red meat intake. (A) shows which ions are at higher levels in high red meat 
intake samples compared to no red meat intake; (B) exhibits those ions higher in no red meat 
intake samples than in high red meat intake. Numbered columns relate to the ions labeled in 
Table 1. 
Figure 3. (A) UPLC ESI+ chromatogram of the polar extract of a serum sample. (B) The 
scores plot displaying the separation between the two sample groups (no red meat intake = 
red; high red meat intake = blue). Explained variance (R2) was 94%, predictive ability (Q2) 
was 89%, and root-mean-square error of validation (RMSEV) was 17%. (C) The loadings 
plots which correspond to the scores in B. Indicated in blue (n = 15) are metabolites which 
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are metabolites which significantly differ between groups (higher in high red meat intake, no 
significant ions were found for no red meat intake group). These are further emphasized by 
the S-line-plot (D) and their relative variable importance to the model 
Figure 4. Graphical representation of the mean relative abundances of the molecules found to 
be significantly different between sample groups acquired in positive mode for high red meat 
intake. (exhibit those ions higher in high red meat intake group samples than in no red meat 
intake), no significant different ions were found in the no red meat intake group). Numbered 
columns relate to the ions labeled in Table 2 for both levels of red meat intake. 
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Highlights 
 
 
• An intervention study was undertaken in health participants with a high red meat 
intake and no red meat intake for six weeks. 
• Utilization of high resolution mass spectrometry (liquid chromatography-quadrupole 
time-of-light-mass spectrometry, UPLC-QTof-MS) and chemometrics for biomarkers 
identification. 
• Identification of possible biomarkers of red meat consumption were found between 
groups. 
• Positive identification of Type 2 Diabetes biomarkers were found in the high  red 
meat intake group. 
 
